QL
LGND icon

Quarry LP’s Ligand Pharmaceuticals LGND Stock Holding History

Quarry LP’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,010
Closed -$202K – 2482
2026
Q1 		$202K Buy
+1,010
New +$200K 0.04% 335
2025
Q3 		– Sell
-999
Closed -$114K – 2356
2025
Q2 		$114K Buy
999
+499
+100% +$53.3K 0.02% 512
2025
Q1 		$52.6K Sell
500
-700
-58% -$79.2K 0.01% 777
2024
Q4 		$129K Buy
+1,200
New +$136K 0.02% 362
2023
Q4 		– Sell
-1,500
Closed -$89.9K – 1508
2023
Q3 		$89.9K Buy
+1,500
New +$98.7K 0.02% 217

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's LGND Position: Q2 2026 in Review

Quarry LP sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 1,010 shares — an estimated $202K sold.

Quarry LP first reported a position in LGND in Q3 2023 and held it in 5 quarters. The position peaked at $202K in Q1 2026. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Quarry LP reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Quarry LP sold 1,010 Ligand Pharmaceuticals shares in Q2 2026, an estimated $202K.
  • Quarry LP first reported a position in Ligand Pharmaceuticals in Q3 2023 and held it in 5 quarters.
  • Quarry LP's Ligand Pharmaceuticals position peaked at $202K in Q1 2026.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.